Enterovirus A71(EV-A71)is the major causative pathogen for severe hand-foot-mouth disease(HFMD),a predominantly childhood-associated communicable disease.The mechanisms that children manifest severe disease progressio...Enterovirus A71(EV-A71)is the major causative pathogen for severe hand-foot-mouth disease(HFMD),a predominantly childhood-associated communicable disease.The mechanisms that children manifest severe disease progression while adults typically exhibit milder or asymptomatic infections remain incompletely characterized,which hinders the development of effective therapy against this disease.Herein,using the newborn mouse model of EV-A71 infection,we uncovered that the underdevelopment of T cells closely associated with the severity of EV-A71 infection,and EV-A71 infection dramatically impaired T-cell immune response.Moreover,the dysfunction of T-cell immunity contributes to the pathogenesis of EV-A71 infection,as the loss of T cells made neonatal mice highly vulnerable to EV-A71 infection.To further assess the relationship between T-cell immunity and HFMD,we enrolled a cohort of 145 pediatric patients with laboratory-confirmed EV-A71 infection and found that the compromised T-cell immune response is associated with the severity of EV-A71-caused HFMD in these children.Furthermore,we found that the treatment of newborn mice with Astragaloside A,a saponin from the medicinal herb Astragalus membranaceus,showed potent in vivo therapeutic efficacy against EV-A71 infection in a T-cell-dependent manner.In conclusion,these findings uncover the interaction between EV-A71 infection and T-cell immunity,provide novel insights onto the physiological impacts of T cells on the pathogenesis of EV-A71 infection and HFMD,and find a promising immunotherapeutic strategy to treat this viral disease.展开更多
Human enterovirus A71(EV-A71)is a major causative agent of hand,foot and mouth disease(HFMD),which poses a significant public health threat,particularly among young children.Mitochondrial antiviral signaling protein(M...Human enterovirus A71(EV-A71)is a major causative agent of hand,foot and mouth disease(HFMD),which poses a significant public health threat,particularly among young children.Mitochondrial antiviral signaling protein(MAVS)and interferon regulatory factor 3(IRF3)are vital proteins for the induction of type I interferons(IFN-I)and downstream interferon-stimulated genes(ISGs)during EVA71 infection.While posttranslational modifications are known to critically influence viral infection processes,the mechanisms by which EV-A71 exploits host deubiquitinases(DUBs)for immune evasion remain poorly understood.In this study,we demonstrated that EV-A71 infection upregulated ubiquitinspecific protease 5(USP5)expression.Knockdown of USP5 not only inhibited EV-A71 replication but also observably increased the production of IFN-I and ISGs.Furthermore,USP5 also regulated the replication of EV-D68 and CVA16 and the production of IFN-I and ISGs.Mechanistically,USP5 physically interacted with MAVS and IRF3 and reduced the K63-linked polyubiquitination of MAVS and IRF3.Conversely,USP5 knockdown increased the K63-linked polyubiquitination of MAVS and IRF3,thereby accelerating the phosphorylation of IRF3 and increasing IFN-I production during EV-A71 infection.Furthermore,pharmacological inhibition of USP5 with the small-molecule inhibitor PR-619 significantly potentiated the antiviral effects of IFN against EV-A71.Collectively,our findings reveal a previously unrecognized role of USP5 in facilitating EV-A71 immune evasion by dampening MAVSand IRF3-mediated antiviral signaling.These insights provide a novel therapeutic avenue for combating EV-A71 infection through targeted modulation of the USP5-IRF3 axis.展开更多
手足口病（Hand,foot and mouth disease,HFMD）是一种具有高度传染性的病毒性传染病,通常夏秋季高发于幼儿和儿童;若患儿并发呼吸和循环功能障碍、神经系统受累等临床症状称为重症HFMD。少数重症病例可出现肺水肿、脑炎和急性弛缓性麻...手足口病（Hand,foot and mouth disease,HFMD）是一种具有高度传染性的病毒性传染病,通常夏秋季高发于幼儿和儿童;若患儿并发呼吸和循环功能障碍、神经系统受累等临床症状称为重症HFMD。少数重症病例可出现肺水肿、脑炎和急性弛缓性麻痹等罕见的神经或循环系统并发症,甚至导致患儿死亡。引起HFMD最常见的病原是肠道病毒A71型（EV-A71）和柯萨奇病毒A16型（CV-A16）,而EV-A71是引起重症HFMD的主要病原体。EV-A71导致的重症HFMD已成为全球重要的公共卫生问题,减少EV-A71流行范围和预防EV-A71重症HFMD非常重要。EV-A71疫苗是目前最有效的预防重症HFMD发生的措施;中国已经批准了三个厂家的灭活EV-A71疫苗上市并已开展适龄儿童接种,以期预防EV-A71感染引起的重症HFMD,但这种疫苗不能预防其它肠道病毒如CV-A16,CV-A6和CV-A10等引起的HFMD。据文献报道,小分子抑制剂芦平曲韦可以通过阻止EV-A71的3Cpro蛋白活性来抑制EV-A71复制;小干扰RNA和单克隆抗体也可抑制EV-A71复制。研制EV-A71和CVA16双价灭活疫苗是防控HFMD的策略之一,而小分子抑制剂、小干扰RNA和单克隆抗体的研制和应用等也是临床防治HFMD的探索。展开更多
肠道病毒A71型(Enterovirus A71,EV-A71)是手足口病的重要病原体,为研究EV-A71感染人扁桃体上皮细胞后对细胞凋亡和细胞周期的影响,确定ERK1/2、JNK1/2、PI3K/Akt和含半胱氨酸的天冬氨酸蛋白水解酶(Cysteinyl aspartate specific protei...肠道病毒A71型(Enterovirus A71,EV-A71)是手足口病的重要病原体,为研究EV-A71感染人扁桃体上皮细胞后对细胞凋亡和细胞周期的影响,确定ERK1/2、JNK1/2、PI3K/Akt和含半胱氨酸的天冬氨酸蛋白水解酶(Cysteinyl aspartate specific proteinase,Caspase)的作用,本文以人扁桃体上皮细胞系UT-SCC-60B为细胞模型,CCK-8试剂盒检测EV-A71对UT-SCC-60B的抑制率、流式细胞仪检测EV-A71感染组和抑制剂处理组的凋亡和细胞周期、Caspase活力检测试剂盒测定Caspase-3,Caspase-8,Caspase-9活力。EV-A71以感染剂量和感染时间依赖方式抑制UT-SCC-60B增殖;EV-A71感染致UT-SCC-60B发生细胞凋亡,抑制ERK1/2、JNK1/2和PI3K/Akt能够降低UT-SCC-60B细胞凋亡比例;EV-A71感染UT-SCC-60B后发生S期阻滞,抑制ERK1/2、JNK1/2、PI3K/Akt和Caspase阻止UT-SCC-60B发生S期阻滞;EV-A71感染UT-SCC-60B能够活化Caspase-3,Caspase-8,Caspase-9且ERK1/2、JNK1/2和PI3K/Akt调控Caspase-3,Caspase-8,Caspase-9活力。因此,EV-A71能够导致人扁桃体上皮细胞UT-SCC-60B发生凋亡和S期阻滞,并且ERK1/2、JNK1/2、PI3K/Akt和Caspase参与凋亡和S期阻滞的调控。展开更多
手足口病(hand,foot and mouth disease,HFMD)是一种全球性的传染病,其主要病原体为肠道病毒A组71型(Enterovirus group A 71,EV-A71)和柯萨奇病毒A组16型(cosackievirus A 16,CV-A16)。EV-A71感染易引发重症病例及死亡病例,而CV-A16感...手足口病(hand,foot and mouth disease,HFMD)是一种全球性的传染病,其主要病原体为肠道病毒A组71型(Enterovirus group A 71,EV-A71)和柯萨奇病毒A组16型(cosackievirus A 16,CV-A16)。EV-A71感染易引发重症病例及死亡病例,而CV-A16感染所致的症状普遍较轻,且CV-A16容易引发重复感染,但目前其中的机理仍不清楚。本研究比较了EV-A71与CV-A16感染正常人呼吸道上皮细胞16HBE后I型干扰素(Type I interferon,IFN-Ι)产生相关基因的改变。结果发现EV-A71感染后TLR3、TLR7、RIG-I、MDA5、MAVS、MyD88、IRF3、IRF7、IFNα和IFNβ的基因表达量均发生了显著性地上调,而在CV-A16感染后仅MDA5显著性上调;TLR3和IRF3的基因表达水平显著性地下降,而其它基因表达水平均无显著性地变化。此外,病毒滴度和病毒拷贝数的检测结果显示,CV-A16在16HBE上的复制效率明显高于EV-A71。上述结果提示我们EV-A71和CV-A16感染16HBE对其IFN-I产生相关基因表达的影响完全不一样,且CV-A16更容易感染人呼吸道上皮细胞。本研究为EV-A71和CV-A16引起的临床症状差异的机理研究以及CV-A16重复感染的机理研究提供了线索。展开更多
基金supported by the National Natural Science Foundation of China(32200130 to Chong Wang and 82372228 to Yi Xu)the 2023-2024 Annual Scientific Research Project of Traditional Chinese Medicine from Hubei Provincial Administration of Traditional Chinese Medicine(ZY2023Q050 to Chong Wang)Hubei Province Natural Science Funds(2023AFA008 to Xi Zhou).
文摘Enterovirus A71(EV-A71)is the major causative pathogen for severe hand-foot-mouth disease(HFMD),a predominantly childhood-associated communicable disease.The mechanisms that children manifest severe disease progression while adults typically exhibit milder or asymptomatic infections remain incompletely characterized,which hinders the development of effective therapy against this disease.Herein,using the newborn mouse model of EV-A71 infection,we uncovered that the underdevelopment of T cells closely associated with the severity of EV-A71 infection,and EV-A71 infection dramatically impaired T-cell immune response.Moreover,the dysfunction of T-cell immunity contributes to the pathogenesis of EV-A71 infection,as the loss of T cells made neonatal mice highly vulnerable to EV-A71 infection.To further assess the relationship between T-cell immunity and HFMD,we enrolled a cohort of 145 pediatric patients with laboratory-confirmed EV-A71 infection and found that the compromised T-cell immune response is associated with the severity of EV-A71-caused HFMD in these children.Furthermore,we found that the treatment of newborn mice with Astragaloside A,a saponin from the medicinal herb Astragalus membranaceus,showed potent in vivo therapeutic efficacy against EV-A71 infection in a T-cell-dependent manner.In conclusion,these findings uncover the interaction between EV-A71 infection and T-cell immunity,provide novel insights onto the physiological impacts of T cells on the pathogenesis of EV-A71 infection and HFMD,and find a promising immunotherapeutic strategy to treat this viral disease.
基金supported by the National Natural Science Foundation of China(32300133 to SZ.and 32100106 to YR)the China Postdoctoral Science Foundation(2023M730965 to SZ.)+3 种基金the Science and Technology Department of Henan Province(232102311103 to SZ.)the Chinese Academy of Sciences(CAS)Youth Innovation Promotion Association(2023351 to YR)the Hubei Province Natural Science Funds(2023AFA008 and 2023AFB582 to YR)the Open project of the State Key Laboratory of Antiviral Drugs,Henan University(FX3020A030002).
文摘Human enterovirus A71(EV-A71)is a major causative agent of hand,foot and mouth disease(HFMD),which poses a significant public health threat,particularly among young children.Mitochondrial antiviral signaling protein(MAVS)and interferon regulatory factor 3(IRF3)are vital proteins for the induction of type I interferons(IFN-I)and downstream interferon-stimulated genes(ISGs)during EVA71 infection.While posttranslational modifications are known to critically influence viral infection processes,the mechanisms by which EV-A71 exploits host deubiquitinases(DUBs)for immune evasion remain poorly understood.In this study,we demonstrated that EV-A71 infection upregulated ubiquitinspecific protease 5(USP5)expression.Knockdown of USP5 not only inhibited EV-A71 replication but also observably increased the production of IFN-I and ISGs.Furthermore,USP5 also regulated the replication of EV-D68 and CVA16 and the production of IFN-I and ISGs.Mechanistically,USP5 physically interacted with MAVS and IRF3 and reduced the K63-linked polyubiquitination of MAVS and IRF3.Conversely,USP5 knockdown increased the K63-linked polyubiquitination of MAVS and IRF3,thereby accelerating the phosphorylation of IRF3 and increasing IFN-I production during EV-A71 infection.Furthermore,pharmacological inhibition of USP5 with the small-molecule inhibitor PR-619 significantly potentiated the antiviral effects of IFN against EV-A71.Collectively,our findings reveal a previously unrecognized role of USP5 in facilitating EV-A71 immune evasion by dampening MAVSand IRF3-mediated antiviral signaling.These insights provide a novel therapeutic avenue for combating EV-A71 infection through targeted modulation of the USP5-IRF3 axis.
文摘手足口病（Hand,foot and mouth disease,HFMD）是一种具有高度传染性的病毒性传染病,通常夏秋季高发于幼儿和儿童;若患儿并发呼吸和循环功能障碍、神经系统受累等临床症状称为重症HFMD。少数重症病例可出现肺水肿、脑炎和急性弛缓性麻痹等罕见的神经或循环系统并发症,甚至导致患儿死亡。引起HFMD最常见的病原是肠道病毒A71型（EV-A71）和柯萨奇病毒A16型（CV-A16）,而EV-A71是引起重症HFMD的主要病原体。EV-A71导致的重症HFMD已成为全球重要的公共卫生问题,减少EV-A71流行范围和预防EV-A71重症HFMD非常重要。EV-A71疫苗是目前最有效的预防重症HFMD发生的措施;中国已经批准了三个厂家的灭活EV-A71疫苗上市并已开展适龄儿童接种,以期预防EV-A71感染引起的重症HFMD,但这种疫苗不能预防其它肠道病毒如CV-A16,CV-A6和CV-A10等引起的HFMD。据文献报道,小分子抑制剂芦平曲韦可以通过阻止EV-A71的3Cpro蛋白活性来抑制EV-A71复制;小干扰RNA和单克隆抗体也可抑制EV-A71复制。研制EV-A71和CVA16双价灭活疫苗是防控HFMD的策略之一,而小分子抑制剂、小干扰RNA和单克隆抗体的研制和应用等也是临床防治HFMD的探索。
文摘肠道病毒A71型(Enterovirus A71,EV-A71)是手足口病的重要病原体,为研究EV-A71感染人扁桃体上皮细胞后对细胞凋亡和细胞周期的影响,确定ERK1/2、JNK1/2、PI3K/Akt和含半胱氨酸的天冬氨酸蛋白水解酶(Cysteinyl aspartate specific proteinase,Caspase)的作用,本文以人扁桃体上皮细胞系UT-SCC-60B为细胞模型,CCK-8试剂盒检测EV-A71对UT-SCC-60B的抑制率、流式细胞仪检测EV-A71感染组和抑制剂处理组的凋亡和细胞周期、Caspase活力检测试剂盒测定Caspase-3,Caspase-8,Caspase-9活力。EV-A71以感染剂量和感染时间依赖方式抑制UT-SCC-60B增殖;EV-A71感染致UT-SCC-60B发生细胞凋亡,抑制ERK1/2、JNK1/2和PI3K/Akt能够降低UT-SCC-60B细胞凋亡比例;EV-A71感染UT-SCC-60B后发生S期阻滞,抑制ERK1/2、JNK1/2、PI3K/Akt和Caspase阻止UT-SCC-60B发生S期阻滞;EV-A71感染UT-SCC-60B能够活化Caspase-3,Caspase-8,Caspase-9且ERK1/2、JNK1/2和PI3K/Akt调控Caspase-3,Caspase-8,Caspase-9活力。因此,EV-A71能够导致人扁桃体上皮细胞UT-SCC-60B发生凋亡和S期阻滞,并且ERK1/2、JNK1/2、PI3K/Akt和Caspase参与凋亡和S期阻滞的调控。
文摘手足口病(hand,foot and mouth disease,HFMD)是一种全球性的传染病,其主要病原体为肠道病毒A组71型(Enterovirus group A 71,EV-A71)和柯萨奇病毒A组16型(cosackievirus A 16,CV-A16)。EV-A71感染易引发重症病例及死亡病例,而CV-A16感染所致的症状普遍较轻,且CV-A16容易引发重复感染,但目前其中的机理仍不清楚。本研究比较了EV-A71与CV-A16感染正常人呼吸道上皮细胞16HBE后I型干扰素(Type I interferon,IFN-Ι)产生相关基因的改变。结果发现EV-A71感染后TLR3、TLR7、RIG-I、MDA5、MAVS、MyD88、IRF3、IRF7、IFNα和IFNβ的基因表达量均发生了显著性地上调,而在CV-A16感染后仅MDA5显著性上调;TLR3和IRF3的基因表达水平显著性地下降,而其它基因表达水平均无显著性地变化。此外,病毒滴度和病毒拷贝数的检测结果显示,CV-A16在16HBE上的复制效率明显高于EV-A71。上述结果提示我们EV-A71和CV-A16感染16HBE对其IFN-I产生相关基因表达的影响完全不一样,且CV-A16更容易感染人呼吸道上皮细胞。本研究为EV-A71和CV-A16引起的临床症状差异的机理研究以及CV-A16重复感染的机理研究提供了线索。
